Jennifer Waller - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Jennifer Waller's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Jennifer Waller
Verified
Research Director, WebMD
Beats
Politics , Policy , Breaking News , Metro Local
Anything dull.
Content
Immediate fortification of human milk with a bovine milk-derived human milk fortifier in very low birth weight infants: a randomized clinical trial - Journal of Perinatology
By Jennifer Waller, Jane Anne Gorham| Nature Verified AbstractDouble-blind randomized control trial of early addition of a bovine milk-derived human milk fortifier (HMF) in very low birth weight (VLBW) infants (NCT05228535). VLBW infants were randomized to receive bovine milk-derived HMF with first feedings or delayed fortification at 80 ml/kg/day. Anthropometrics were assessed weekly through 36 weeks postmenstrual age (PMA).
The Assessment of Infection Risk in Patients with Vitiligo Undergoing Dialysis for End-Stage Renal Disease: A Retrospective Cohort Study
By Mitchell Hanson, Jennifer Waller, Sarah Tran, Pearl Shah| MDPI@ All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
Immediate fortification of human milk with a bovine milk-derived human milk fortifier in very low birth weight infants: a randomized clinical trial - Journal of Perinatology
By Jennifer Waller, Jane Anne Gorham| Nature Verified AbstractDouble-blind randomized control trial of early addition of a bovine milk-derived human milk fortifier (HMF) in very low birth weight (VLBW) infants (NCT05228535). VLBW infants were randomized to receive bovine milk-derived HMF with first feedings or delayed fortification at 80 ml/kg/day. Anthropometrics were assessed weekly through 36 weeks postmenstrual age (PMA).
Company Info
WebMD
WebMD is a prominent provider of health information services, blending healthcare and technology. Founded in 1995 and headquartered in Elmwood Park, New Jersey, the company serves consumers, healthcare professionals, and institutions through its digital platforms. WebMD's flagship website attracts over 20 million monthly visitors, offering resources like symptom checkers and wellness content. The WebMD Symptom Checker app allows users to assess symptoms and receive care recommendations. For healthcare professionals, WebMD offers a range of solutions, including Medscape, which provides continuing medical education and clinical reference tools for over 1.6 million healthcare professionals. WebMD Envoy facilitates electronic data interchange for claims processing and eligibility verification, while WebMD Practice Services delivers practice management software for scheduling and billing. The company also partners with media and tech platforms to distribute its health content, enhancing its reach and impact in the digital health space.
New York, New York, United States
'+1 212-624-3700
Founded: 1995